Search Results Label

Seqirus has been on the front line of pandemic preparedness for more than a century. Learn more about our rapid vaccine production capabilities.

https://www.seqirus.com/expertise/influenza/pandemic-response-solutions

Seqirus is one of the largest influenza vaccine companies in the world, with state-of-the-art manufacturing facilities on three continents. Learn more.

https://www.seqirus.com/manufacturing/global-manufacturing-network

Seqirus brings multifaceted expertise to influenza prevention, employing both egg and cell-based technologies to meet the global community's needs.

https://www.seqirus.com/expertise

Seqirus announced today that the accelerated development of cell-based manufacturing technology at its manufacturing facility in Holly Springs, North Carolina, has delivered a four-fold increase in seasonal influenza vaccine output in just two years, strengthening the United States’ capacity to respond to pandemic threats.

https://www.seqirus.com/news/seqirus-announces-major-advances-in-pandemic-preparedness

This EU Flu Day, Seqirus confirms record number of influenza vaccines delivered across Europe to meet increased demand

https://www.seqirus.com/news/eu-flu-day-seqirus-confirms-influenza-vaccines-delivered-across-eu

Read the latest news from Seqirus, a world leader in developing and producing influenza vaccines.

https://www.seqirus.com/news/seqirus-presents-new-clinical-data-reinforcing-mf59

Read the latest news from Seqirus, a world leader in developing and producing influenza vaccines.

https://www.seqirus.com/news/seqirus-applauds-the-executive-order-to-accelerate-enhanced-protection-against-influenza-threats

Seqirus, as a member of the CSL group, is bound by CSL's Code of Responsible Business Practice. Access our annual financial and diversity disclosures.

https://www.seqirus.com/our-company/corporate-responsibility/disclosures

Seqirus Begins Shipping 2020/21 Influenza Vaccines to U.S. Market

https://www.seqirus.com/news/seqirus-begins-shipping-influenza-vaccines-to-us-market

Seqirus, a global leader in influenza prevention, today opened its new Italian headquarters in San Martino, Monteriggioni, just outside Siena.

https://www.seqirus.com/news/seqirus-opens-new-italian-headquarters